These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23476790)

  • 1. Display of the Viral Epitopes on Lactococcus lactis: A Model for Food Grade Vaccine against EV71.
    Varma NR; Toosa H; Foo HL; Alitheen NB; Nor Shamsudin M; Arbab AS; Yusoff K; Abdul Rahim R
    Biotechnol Res Int; 2013; 2013():431315. PubMed ID: 23476790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine.
    Raha AR; Varma NR; Yusoff K; Ross E; Foo HL
    Appl Microbiol Biotechnol; 2005 Jul; 68(1):75-81. PubMed ID: 15635459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant lactococcus lactis secreting viral protein 1 of enterovirus 71 and its immunogenicity in mice.
    Xu P; Wang Y; Tao L; Wu X; Wu W
    Biotechnol Lett; 2019 Jul; 41(6-7):867-872. PubMed ID: 31119429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment.
    Ch'ng WC; Stanbridge EJ; Ong KC; Wong KT; Yusoff K; Shafee N
    J Med Virol; 2011 Oct; 83(10):1783-91. PubMed ID: 21837796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis.
    Ribeiro LA; Azevedo V; Le Loir Y; Oliveira SC; Dieye Y; Piard JC; Gruss A; Langella P
    Appl Environ Microbiol; 2002 Feb; 68(2):910-6. PubMed ID: 11823235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with r-Lactococcus lactis expressing outer membrane protein A of Shigella dysenteriae type-1: evaluation of oral and intranasal route of administration.
    Yagnik B; Sharma D; Padh H; Desai P
    J Appl Microbiol; 2017 Feb; 122(2):493-505. PubMed ID: 27860045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a hepatitis A virus antigen in Lactococcus lactis and Escherichia coli and evaluation of its immunogenicity.
    Berlec A; Malovrh T; Zadravec P; Steyer A; Ravnikar M; Sabotič J; Poljšak-Prijatelj M; Štrukelj B
    Appl Microbiol Biotechnol; 2013 May; 97(10):4333-42. PubMed ID: 23371298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface display of hirame novirhabdovirus (HIRRV) G protein in Lactococcus lactis and its immune protection in flounder (Paralichthys olivaceus).
    Zhao L; Tang X; Sheng X; Xing J; Zhan W
    Microb Cell Fact; 2019 Aug; 18(1):142. PubMed ID: 31434565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections.
    Liu J; Zhao B; Xue L; Wu J; Xu Y; Liu Y; Qin C
    Virol J; 2020 Apr; 17(1):58. PubMed ID: 32321526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.
    Parlane NA; Grage K; Lee JW; Buddle BM; Denis M; Rehm BH
    Appl Environ Microbiol; 2011 Dec; 77(24):8516-22. PubMed ID: 21984246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterovirus 71 vaccine: close but still far.
    Zhang D; Lu J; Lu J
    Int J Infect Dis; 2010 Sep; 14(9):e739-43. PubMed ID: 20400350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice.
    Wang M; Jiang S; Wang Y
    Biochem Biophys Res Commun; 2013 Jan; 430(1):387-93. PubMed ID: 23159634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus.
    Wu Y; Zhu R; Xu L; Li Y; Li S; Yu H; Li S; Zhu H; Cheng T; Xia N
    Vaccine; 2017 May; 35(20):2728-2735. PubMed ID: 28408118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vaccine of Lactococcus lactis harbouring pandemic H1N1 2009 haemagglutinin1 and nisP anchor fusion protein elevates anti-HA1 sIgA levels in mice.
    Joan SS; Pui-Fong J; Song AA; Chang LY; Yusoff K; AbuBakar S; Rahim RA
    Biotechnol Lett; 2016 May; 38(5):793-9. PubMed ID: 26758876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of EV71 vaccine candidates.
    Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
    Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus.
    Wang W; Song Y; Liu L; Zhang Y; Wang T; Zhang W; Li K; Qi X; Gao Y; Gao L; Liu C; Zhang Y; Wang Y; Pan Q; He G; Wang X; Cui H
    Microb Cell Fact; 2019 Jan; 18(1):21. PubMed ID: 30704494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.